pocketful logo light
pocketful logo light
Ajooni Biotech Ltd logo

Ajooni Biotech Ltd

NSE: AJOONI BSE: 535040

₹3.80

(0%)

Wed, 17 Jun 2026, 11:41 am

Ajooni Biotech Price to Sales Ratio (P/S)

Particulars201920202021202220232024
Price to earnings ratio18.4381.5064.202.0423.9228.60
Price to book ratio0.401.944.110.831.211.10
Price to sales ratio0.160.600.910.030.650.84
Price to cash flow ratio053.1921.4202.260
Enterprise value11.29Cr36.96Cr72.63Cr7.16Cr53.43Cr91.57Cr
Enterprise value to EBITDA ratio9.1022.4023.542.5823.7324.54
Debt to equity ratio0.320.430.330.120.050.02
Return on equity %02.376.553.875.125.16

Ajooni Biotech Ltd Price to Sales Ratio

The Ajooni Biotech Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Ajooni Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Ajooni Biotech Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Ajooni Biotech Ltd (NSE: AJOONI, BSE: 535040) is currently trading at ₹3.80, with a market capitalization of ₹0. As a leading company in the Miscellaneous sector and Miscellaneous industry, monitoring the Ajooni Biotech Ltd Price to Sales Ratio is essential for fundamental analysis.

Ajooni Biotech Ltd Price to Sales Ratio Current Value

The current Ajooni Biotech Ltd Price to Sales Ratio stands at 0.84.

The latest Ajooni Biotech Ltd Price to Sales Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Ajooni Biotech Ltd Price to Sales Ratio Historical Trend

The Ajooni Biotech Ltd Price to Sales Ratio has shown the following historical trend:

  • 2024: 0.84
  • 2023: 0.65
  • 2022: 0.03
  • 2021: 0.91
  • 2020: 0.60

The recent rise in Ajooni Biotech Ltd Price to Sales Ratio suggests strengthening valuation trends and improving market sentiment.

What Ajooni Biotech Ltd Price to Sales Ratio Indicates for Investors

The Ajooni Biotech Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/S ratio helps evaluate valuation relative to company revenue.

Ajooni Biotech Ltd Price to Sales Ratio Analysis Summary

The Ajooni Biotech Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Ajooni Biotech Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Ajooni Biotech Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account

Enter your phone number